Are most patients beginning lebrikizumab already previously treated with another biologic, or are some biologic-naïve?

Featuring James Del Rosso, DO | Clinical Advisor | Adjunct Clinical Professor (Dermatology)Touro University NevadaHenderson, NVResearch Director/ Principal Investigator/ Clinical DermatologistJDR Dermatology ResearchLas Vegas, NV | Published October 01, 2025